By Daniel Peterson
According to a new report by Roland Berger Strategy Consultants, increasing price and cost pressure, regulatory changes and expiring patents are leading to shrinking margins in the pharmaceutical industry. So, more and more, pharmaceutical manufacturers are “right-sizing” their operations to wring the most efficiency from limited resources.
Despite smaller budgets, contamination control is still one of a pharmaceutical manufacturer’s most important responsibilities. They face serious cleaning challenges and need to comply with government regulations, as well as customer and insurance audits. The bottom line: companies are responsible for protecting their people and products.